Law.com Subscribers SAVE 30%

Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.

Search

We found 2,751 results for "Product Liability Law & Strategy"...

What's Reasonable to Expect?
A number of jurisdictions have adopted one version or another of the reasonable expectations doctrine.
The Limitations of Liability Coverage Under 'Designated Premises' Policies
Where CGL coverage is not available, some policyholders have attempted to obtain general liability coverage under policies that provide a more limited coverage, namely policies that provide coverage for bodily injury or property damage liability arising out of the ownership, maintenance or use of a particular "designated premises."
Pharmaceutical Companies, Off-Label Promotion And Qui Tam Actions
In pharmaceutical actions, most false claims <i>qui tam</i> actions brought by whistleblowers involve off-label promotion, kickbacks, pricing allegations, and reimbursement abuses. Although these start out as civil lawsuits, they often end with the DOJ pressing charges against the pharmaceuticals manufacturer.
Staying Afloat Through the Flood
This article discusses key issues that companies should consider in pursuing contingent business interruption claims arising from the Mississippi River flooding.
Don't Assume Your e-Profits Away
Perhaps we all have heard the warning given by my late high school geometry teacher about what "U and Me" become when we make an (unwarranted) <i>assumption</i>. However aged my former teacher's "assume" joke may have been, I think it is an excellent reminder of why overt and implied assumptions underlying e-commerce must be considered in making business plans.
Issues Regarding the 2010 Patient Protection Act
If not politically, at least analytically, given local governments' experience with insurance reform and the financial assumptions used in the Patient Protection and Affordable Care Act, the PPACA should be considered DOA!
FCPA: Recent Enforcement Activity Sounds Warning for Financial Services Industry
When Cheryl J. Scarboro, Chief of the SEC's Foreign Corrupt Practices Act (FCPA) enforcement unit, remarked in November 2010 that her unit "will continue to focus on industry-wide sweeps and [that] no industry is immune from [FCPA] investigation," the financial services industry would have been wise to take notice.
Movers & Shakers
Who's going where; who's doing what.
Drug & Device News
Recent news of importance.
Federal District Court Applies Supreme Court's 'Nerve Center' Test
While corporate executives and their advisers will no doubt appreciate the certainty provided by the Supreme Court's affirmation of the "nerve center" test for determining a corporation's principal place of business, they must be mindful that the courts will focus on the actual "center of direction, control, and coordination" rather than artificial attempts to manipulate jurisdiction.

MOST POPULAR STORIES